Genetic testing involves molecular analysis of human DNA, RNA, genes, and chromosomes to detect whether or not a person has an inherited trait or disorder, an acquired genetic alteration, a spontaneous genetic mutation, or is a carrier of a gene that could lead to a particular disorder or disease.
Many insurances are requiring pre-authorizations for genetic and molecular testing. If noted above the patient’s insurance company is requiring the ordering physician to obtain a pre-authorization before additional testing can be performed. The Hyperlink below will provide a printer friendly alert values pages. Once open click the Printer Icon on the left side in the toolbar just above the form.
The molecular diagnostic testing performed at RML uses a variety of methods including Polymerase Chain Reaction (PCR) and the Invader technology®. All molecular diagnostic testing will include a written pathology report. Result turnaround time will vary between 7-14 days.
Click here to learn more about our Cystic Fibrosis Carrier Screening.
Click on the Test Name below to view the Test Directory for more information and collection instructions.
|Test Name:||Order Name:||Test Number:||Specimen:|
|EGFR Mutation Analysis (TK Domain) *NEW||EGFR MUTAT||9103095||Paraffin Block|
|KRAS Mutation Analysis (K-ras)||KRAS MUTAT||9100040||Paraffin Block|
|JAK 2 Mutation (V617F) Analysis||JAK2 MUTAT||9100185||EDTA WB|
|Cystic Fibrosis 46 specific mutations||CYSTIC GEN||1515700||EDTA WB|
|Factor 5 (V) Leiden Mutation Analysis||FACT 5 LEI||9107735||EDTA WB|
|MTHFR, DNA Mutation Analysis (C665T & A1286C)
|Factor 2 (II) Prothrombin Mutation 20210 Analysis||FAC II MUT||1515300||EDTA WB|
Third Wave Technology® registered tradmark of Third Wave Technologies, Madison, Wisconsin.